• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SenesTech Announces Appointment of Vector and Pest Control Industry Veteran Joel Fruendt as Chief Executive Officer

    11/14/22 9:10:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials
    Get the next $SNES alert in real time by email

    PHOENIX, Nov. 14, 2022 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the appointment of Joel Fruendt as SenesTech's new Chief Executive Officer, succeeding Ken Siegel. Mr. Siegel, who is expected to retire at the end of the year, will remain as an Executive Director, in a consultative role, through the transition period. This leadership transition is part of SenesTech's ongoing strategic plan to drive the commercialization of ContraPest, its flagship product.

    SenesTech, Inc. has developed and is in the process of commercializing a proprietary technology for managing animal pest populations, primarily rat populations, through fertility control. (PRNewsfoto/SenesTech, Inc.)

    Mr. Fruendt is a seasoned chief executive with over 15 years of leadership experience in the vector and pest control industry where he was the Vice President and General Manager of Clarke Environmental Inc., a leading vector and pest control products and services company. From Clarke, he brings extensive expertise in the development and manufacturing of EPA registered chemical control products, commercialization and sales of those products, and leading large sales and service organizations. Most recently he served as President and CEO of a global manufacturing company in the reflective technology and safety industry, where he spearheaded their successful revenue and profit growth through innovation and efficiency initiatives.

    Mr. Fruendt brings a passion and commitment to sustainable, effective solutions to pest control challenges, and a direct connection to SenesTech's industry partners.

    "I believe that SenesTech has developed an effective, sustainable, and earth-friendly tool for integrated pest management that focuses on fertility control as a method to reduce overall rodent populations," said Mr. Fruendt. "The industry is in need of an IPM tool which reduces reliance on lethal chemicals and offers a sustainable solution, and ContraPest is the answer."

    "Over the past three and a half years, we have laid the groundwork for the successful commercialization of ContraPest. We have completed necessary field work, we have improved the product's performance and delivery, we have initiated the needed awareness in the commercial end user market, and we have enhanced our relationships with pest control partners," said Mr. Siegel. "This is an ideal time for Joel to bring his unique skills and experience to further those relationships and take ContraPest to the next level."

    "We very much appreciate the contributions Ken has made. He created the foundation for growth, and set us on the right trajectory. With this foundation, we felt comfortable in starting an extensive and thorough process to identify a new CEO to take us to the next stage," said Dr. Jamie Bechtel, SenesTech's Board Chair.  "Through that process, we had the opportunity to evaluate a strong pool of applicants and impressive candidates emerged. However, individually and collectively, the Board came to a unanimous decision. Joel Fruendt was selected as the next CEO for SenesTech for several reasons, including his leadership experience, his experience as a sales executive, his extensive contacts in the pest control industry, and the importance he places on team building and cross-team collaboration."

    About SenesTech

    We are "The Pest Control Difference" for the 21st century. We are rodent fertility control specialists fueled by our passion to create a healthy environment by virtually eliminating rodent pest populations. We keep an inescapable truth in mind. Two rats and their descendants can be responsible for the birth of up to 15,000 pups after a year. We invented ContraPest, the only U.S. EPA registered contraceptive for male and female rats. ContraPest fits seamlessly into all integrated pest management programs, greatly improving the overall goal of effective rat management. We strive for clean cities, efficient businesses and happy households – with a product that was designed to be effective and sustainable without killing rats.  At SenesTech, we don't just eliminate rats. We make a better world.

    For more information visit https://senestech.com/  and https://contrapeststore.com. 

    Safe Harbor Statement

    This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, among others, our strategic plan to drive the commercialization of ContraPest; our belief that Mr. Fruendt brings a passion and commitment to sustainable, effective solutions to pest control challenges, and a direct connection to our industry partners; Mr. Fruendt's belief that we have developed an effective, sustainable, and earth-friendly tool for integrated pest management that focuses on fertility control as a method to reduce overall rodent populations; Mr. Fruendt's belief that the industry is in need of an IPM tool which reduces reliance on lethal chemicals and offers a sustainable solution, and ContraPest is the answer; our belief that over the past three and a half years, we have laid the groundwork for the successful commercialization of ContraPest; our belief that hiring Mr. Fruendt as our Chief Executive Officer will allow us to take ContraPest to the next level; and our belief that Mr. Siegel created our foundation for growth and set us on the right trajectory. Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the impacts and implications of the COVID-19 pandemic, the successful commercialization of our products, market acceptance of our products, regulatory approval and regulation of our products and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and our Registration Statement on Form S-1, filed with the SEC on October 24, 2022. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

    CONTACT: 

    Investors: Robert Blum, Joe Dorame, Joe Diaz, Lytham Partners, LLC,

    602-889-9700, senestech@lythampartners.com

    Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc.,

    928-779-4143

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/senestech-announces-appointment-of-vector-and-pest-control-industry-veteran-joel-fruendt-as-chief-executive-officer-301676539.html

    SOURCE SenesTech, Inc.

    Get the next $SNES alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SNES

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SNES
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SenesTech Expands Distribution of Evolve® Rodent Birth Control™ into Bermuda

    SURPRISE, Ariz., June 4, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in birth control solutions for managing rodent populations, today announced the expansion of its Evolve® Rodent Birth Control™ products into Bermuda through a distribution agreement with Animal and Garden House, marking another step in the Company's growing presence in environmentally sensitive island markets. "Bermuda presents a unique environment for pest management solutions. As a small island with a dense population and close proximity between urban areas and surrounding marine ecosystems, the use of traditional rodenticides has long requi

    6/4/26 8:00:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Announces Amendment to Equity Incentive Plan Proposal

    PHOENIX, June 3, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) ("SenesTech" or the "Company"), today announced that its Board of Directors has approved an amendment to the proposed changes to the Company's 2018 Equity Incentive Plan (the "2018 Plan"), which is being presented for stockholder approval at the Company's 2026 Annual Meeting of Stockholders scheduled for June 9, 2026. As previously disclosed in the Company's definitive Proxy Statement filed on April 29, 2026, stockholders are being asked to approve an amendment to the 2018 Plan to increase the number of shares available for future equity awards. Following furth

    6/3/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026

    SURPRISE, Ariz., May 19, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2026 Investor Conference, taking place virtually on Thursday, May 28, 2026. Company WebcastThe webcast presentation will take place at 2:30 p.m. ET on Thursday, May 28, 2026. The webcast can be accessed by visiting the conference home page at http

    5/19/26 4:30:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    SEC Filings

    View All

    SEC Form DEFA14A filed by SenesTech Inc.

    DEFA14A - SenesTech, Inc. (0001680378) (Filer)

    6/4/26 4:02:35 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SEC Form DEFA14A filed by SenesTech Inc.

    DEFA14A - SenesTech, Inc. (0001680378) (Filer)

    6/3/26 4:06:13 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SEC Form DEFA14A filed by SenesTech Inc.

    DEFA14A - SenesTech, Inc. (0001680378) (Filer)

    5/27/26 4:01:48 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $53,486 worth of shares (32,120 units at $1.67) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    5/18/26 8:11:14 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Chief Executive Officer Edell Michael bought $5,013 worth of shares (3,000 units at $1.67) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    5/18/26 4:40:22 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $4,407 worth of shares (3,000 units at $1.47) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    4/30/26 7:19:04 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $53,486 worth of shares (32,120 units at $1.67) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    5/18/26 8:11:14 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Chief Executive Officer Edell Michael bought $5,013 worth of shares (3,000 units at $1.67) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    5/18/26 4:40:22 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $4,407 worth of shares (3,000 units at $1.47) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    4/30/26 7:19:04 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Leadership Updates

    Live Leadership Updates

    View All

    SenesTech Appoints Michael Edell as President and Chief Executive Officer to Drive Revenue Growth and Scalable Sales Channels

    SURPRISE, Ariz., May 7, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", )), a leader in humane pest control solutions, today announced the appointment of Michael Edell as President and Chief Executive Officer, effective May 6, 2026. The Company also announced Board leadership transition updates to support SenesTech's next phase of commercial growth and operational execution. Mr. Edell brings a proven track record of building and scaling consumer product businesses, with deep expertise in e-commerce, direct-to-consumer execution, and business

    5/7/26 8:30:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Announces CEO Transition Plan

    Board To Initiate Search For New Leadership As Current CEO Plans Retirement Dr. Jamie Bechtel Named Interim Executive Chair To Further Support Transition PHOENIX, Jan. 28, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in fertility control solutions for managing rodent populations, today announced that Joel Fruendt, President and Chief Executive Officer, has informed the Board of Directors of his intent to retire. The Board will commence a formal search for a successor. Mr. Fruendt will continue to serve as President and CEO until the search is completed or until June 30, 2026, whichever occurs first.

    1/28/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Names Nicole Williams as Chief Revenue Officer

    PHOENIX, Feb. 16, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today reported the appointment of Nicole Williams as Chief Revenue Officer. Ms. Williams was previously Chief Strategy Officer, and this appointment is part of an expansion and restructuring of the sales organization and commercialization efforts. The restructuring of the team comes after yet another quarter and fiscal ye

    2/16/23 9:00:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Financials

    Live finance-specific insights

    View All

    SenesTech Reports Record Direct-to-Consumer and Subscription Growth Following Strategic E-Commerce Transition

    In-house e-commerce transition and new CEO expected to support scalable recurring revenue growth strategySURPRISE, Ariz., May 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products today announced financial results for the first quarter ended March 31, 2026 and provided an update on the Company's acceleration of revenue under newly appointed Chief Executive Officer, Michael Edell. Q1 2026 Financial HighlightsRevenue increased 2% to $493,

    5/12/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026

    Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern timePHOENIX, May 7, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products, will report financial results for its first quarter 2026, ended March 31, 2026, after the market close on Tuesday, May 12, 2026. The Company has scheduled a conference call that same day, Tuesday, May 12, 2026, at 5:00 pm ET, to review the results. First Quarter

    5/7/26 4:30:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Announces 2025 Financial Results Driven by Strong Growth in E-Commerce

    SURPRISE, Ariz., March 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in birth control solutions for managing rodent populations, today announced financial results for the fourth quarter and the full year ended December 31, 2025. 2025 HighlightsRevenue increased by 20% to $2.2 million in 2025 as compared to 2024, driven by strong growth in the Company's overall e-commerce channels despite the impact associated with the Company's transition to directly managing Amazon sales of Evolve® Rat and Evolve Mouse. Excluding this transition-related impact, we estimate re

    3/12/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:28:08 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:12:23 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SEC Form SC 13G filed by SenesTech Inc.

    SC 13G - SenesTech, Inc. (0001680378) (Subject)

    11/12/24 4:30:48 PM ET
    $SNES
    Agricultural Chemicals
    Industrials